Want to see TSE:BCT full AI Analyst Report?

BriaCell Therapeutics (BCT) Cash flow

111 Followers

BriaCell Therapeutics Cash Flow

TSE:BCT's free cash flow for Q4 2026 was C$-5.88M. For the 2026 fiscal year, TSE:BCT's free cash flow was decreased by C$-686.57K and operating cash flow was C$-5.88M. See a summary of the company’s cash flow.

Cash Flow	Jul 26	Jul 25	Jul 24	Jul 23	Jul 22
Operating Cash Flow	$ -29.07M	$ -28.51M	$ -24.13M	$ -23.74M	$ -12.48M
Investing Cash Flow	$ -3.86M	$ -7.74M	$ -681.80K	$ 0.00	$ 0.00
Financing Cash Flow	$ 32.28M	$ 46.00M	$ 4.42M	$ 3.95M	$ -3.74M
End Cash Position	$ 10.12M	$ 10.53M	$ 862.09K	$ 21.25M	$ 41.04M
Free Cash Flow	$ -29.20M	$ -28.51M	$ -24.58M	$ -23.74M	$ -12.48M